| Date Filed | Type | Description |
| 08/22/2023 |
4
| Trizzino John (EVP, CCO and CBO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 317 shares
@ $7.14, valued at
$2.3k
Exercised 655 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
4
| Trizzino John (EVP, CCO and CBO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 4,609 shares
@ $6.52, valued at
$30.1k
Paid exercise price by delivering 2,471 shares
@ $6.52, valued at
$16.1k
Exercised 4,609 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Kelly James Patrick (EVP, CFO and Treasurer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 4,609 shares
@ $6.52, valued at
$30.1k
Paid exercise price by delivering 2,471 shares
@ $6.52, valued at
$16.1k
Exercised 4,609 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Herrmann John A III (EVP, Chief Legal Officer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 4,609 shares
@ $6.52, valued at
$30.1k
Paid exercise price by delivering 1,780 shares
@ $6.52, valued at
$11.6k
Exercised 4,609 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Glenn Gregory M (President, R&D) has filed a Form 4 on NOVAVAX INC|
Txns:
| Bought 3,000 shares
@ $7.4845, valued at
$22.5k
Bought 2,000 shares
@ $7.044, valued at
$14.1k
Bought 1,000 shares
@ $6.5, valued at
$6.5k
Exercised 6,298 shares
@ $6.52, valued at
$41.1k
Paid exercise price by delivering 2,432 shares
@ $6.52, valued at
$15.9k
Exercised 6,298 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Trizzino John (EVP, CCO and CBO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 100,100 options to buy
@ $6.97, valued at
$697.7k
Granted 86,670 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Kelly James Patrick (EVP, CFO and Treasurer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 42,350 options to buy
@ $6.97, valued at
$295.2k
Granted 36,670 restricted stock units
@ $0 |
|
| 03/09/2023 |
4
| Herrmann John A III (EVP, Chief Legal Officer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 44,280 options to buy
@ $6.97, valued at
$308.6k
Granted 38,330 restricted stock units
@ $0 |
|
| 01/25/2023 |
4
| Jacobs John C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 290,700 options to buy
@ $11.92, valued at
$3.5M
Granted 249,590 restricted stock units
@ $0 |
|
| 01/25/2023 |
3
| Jacobs John C (President and CEO) has filed a Form 3 on NOVAVAX INC |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2022 |
4
| Herrmann John A III (EVP, Chief Legal Officer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 772 shares
@ $37.07, valued at
$28.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 08/23/2022 |
4
| Trizzino John (EVP, CCO and CBO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 317 shares
@ $36.22, valued at
$11.5k
Exercised 655 restricted stock units
@ $0 |
|
| 08/18/2022 |
4
| Kelly James Patrick (EVP, CFO and Treasurer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 1,144 shares
@ $42.88, valued at
$49.1k
Exercised 2,367 restricted stock units
@ $0 |
|
| 06/28/2022 |
4
| Trizzino John (EVP, CCO and CBO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 278 shares
@ $51.67, valued at
$14.4k
Exercised 833 restricted stock units
@ $0 |
|
| 06/28/2022 |
4
| Herrmann John A III (EVP, Chief Legal Officer) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 278 shares
@ $51.67, valued at
$14.4k
Exercised 833 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| YOUNG JAMES F (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 1,400 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 700 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| MCMANUS MICHAEL A JR (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 700 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 700 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| King Rachel K. (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 700 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| DOUGLAS RICHARD (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 700 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| Alton Gregg H (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Exercised 700 restricted stock units
@ $0 |
|
| 06/14/2022 |
4
| MOTT DAVID M (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 4,600 options to buy
@ $40.62, valued at
$186.9k
Granted 3,100 restricted stock units
@ $0 |
|
| 06/14/2022 |
4
| MCGLYNN MARGARET G (Director) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 4,600 options to buy
@ $40.62, valued at
$186.9k
Granted 3,100 restricted stock units
@ $0 |
|
|